AGP Executive Report
Last update: 12 hours agoMedical AI: Microsoft’s diagnostic system scored 83% on 304 complex simulated cases, versus 36% for doctors using reference materials; real-world clinical testing is still needed. Cancer Research: An experimental breast cancer drug cut the risk of progression or death by 59% versus chemotherapy in a Phase 3 trial, though overall survival data are not yet mature. AI Security: Researchers warn that hidden instructions in research materials could steer pharmaceutical AI toward misleading sources, underscoring the need for traceability and oversight. Technology Policy: China’s draft export rules cover AI technologies including large models and agents; developers DeepSeek and MiniMax have registered under the proposed controls. Male Contraception: A federally funded study will test a pill designed to temporarily stop sperm activity, potentially providing six to eight hours of protection. The grant supports investigation of its safety in humans.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.